HOME >> MEDICINE >> NEWS
Primary-care based program reduces thoughts of suicide among older depressed patients

An intervention that includes interaction with a depression care manager reduces levels of depression and thoughts of suicide among older patients with depression, according to a study in the March 3 issue of The Journal of the American Medical Association (JAMA).

Older Americans comprise about 13 percent of the U.S. population, yet account for 18 percent of all suicide deaths, according to background information in the article. Depression is the strongest risk factor for late-life suicide and for suicide's precursor, suicidal ideation (thoughts of suicide). The majority of older adults who die by suicide have seen a primary care physician in preceding months. Recent national reports emphasize the public health need for intervention trials to reduce the risk for suicide in late life.

Martha L. Bruce, Ph.D., M.P.H., of Weill Medical College of Cornell University, White Plains, N.Y., and colleagues conducted a study to test the impact of a primary care-based intervention on reducing depression and major risk factors for suicide in older patients. The randomized trial, known as PROSPECT (Prevention of Suicide in Primary Care Elderly: Collaborative Trial), was conducted at 20 primary care practices in New York City, Philadelphia, and Pittsburgh regions, May 1999 through August 2001. The trial included a two-stage, age-stratified (60-74; 75 years and older) depression screening of randomly sampled patients; enrollment included patients who screened positive and a random sample of screened negative patients. This analysis included patients with a depression diagnosis (N=598).

The intervention focused on two major components of care. First was physician knowledge, addressed by a clinical algorithm for treating geriatric depression in a primary care setting. The second was treatment management, put into practice by depression care managers. The intervention was compared with usual care after the physicians were educated about treatment guidelin
'"/>

Contact: Craig Dunhoff
412-624-2607
JAMA and Archives Journals
2-Mar-2004


Page: 1 2

Related medicine news :

1. Community-based care beats standard clinic in lowering heart
2. School-based smoking prevention programs ineffective
3. Mayo Clinic develops first genomic-based test to predict stroke from ruptured brain aneurysm
4. NYUS Duster cautions against FDA approval of race-based pharmaceutical
5. Influenza vaccination programmes for children in USA and Canada based on little evidence
6. Web-based tool to help clinicians make schizophrenia treatment decisions
7. Home-based treatment as effective as hospital-based treatment for hand eczema
8. UGA researchers receive NIH contract to create a stem cell-based drug assay for SMA
9. Broad-based vaccination of wild mice could help reduce lyme disease risk in humans
10. Novel p53 gene-based therapy boosts immune system and reduces tumor size
11. No link found between pneumonitis in breast cancer patients and taxane-based chemotherapies

Post Your Comments:
(Date:3/6/2015)... Follow us on LinkedIn – ... drug refers to testing of absorption, distribution, metabolism, and ... toxicity studies are clubbed together with ADME, it is ... on lowering costs and time during drug development are ... drug development model uses toxicity and efficacy testing in ...
(Date:3/6/2015)... USA (PRWEB) March 06, 2015 Parents ... the fatal reality of substance use disorders. School programs ... to be marginally successful. NOPE, or Narcotics Overdose Prevention ... nationwide, according to Healthline News on Feb. ... illicit and prescription opiate drugs, drug prevention proponents are ...
(Date:3/6/2015)... 06, 2015 Johnson & Johnson and ... on March 5, 2015 in Superior Court in the ... documents, a jury of 12 awarded Mrs. Perry $700,000 ... implanted with an Ethicon TVT Abbrevo plastic sling for ... three women also awarded $5 million in punitive damages. ...
(Date:3/6/2015)... DC (PRWEB) March 06, 2015 Magellan ... nation’s only comprehensive source for key trends and statistics ... spend, medical injectables. Executives from Magellan Rx Management will ... Trend Report: Discover Your Hidden Specialty Drug Spend,” a ... Information Services, Inc. , Specialty drug spend makes up ...
(Date:3/6/2015)... 06, 2015 The Gluten-Free Certification ... Association, is pleased to announce that Dufflet Pastries, ... has expanded their product line of gluten-free treats ... scrumptious and as satisfying as any of their ... and never contains hydrogenated fats or oils, artificial ...
Breaking Medicine News(10 mins):Health News:Growing Need to Reduce Drug Development Costs Drives the Global ADME-Toxicology Testing Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Growing Need to Reduce Drug Development Costs Drives the Global ADME-Toxicology Testing Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:A Harbor Village Detox Clinical Psychologist Encourages School Programs like NOPE to Positively Impact Awareness of Substance Use Disorders 2Health News:Johnson & Johnson Hit with $5.7 Million Verdict in Pelvic Mesh Trial Announces Matthews & Associates Law Firm 2Health News:Johnson & Johnson Hit with $5.7 Million Verdict in Pelvic Mesh Trial Announces Matthews & Associates Law Firm 3Health News:Atlantic Information Services, Magellan Rx Management Partner on Complimentary Webinar Outlining Key Findings of New Medical Pharmacy Trend Report 2Health News:Dufflet Pastries® Impressive Collection of Brownies, Cakes, Pies and Cakelets® Now Includes a Gluten-Free Line Certified By the GFCP. 2Health News:Dufflet Pastries® Impressive Collection of Brownies, Cakes, Pies and Cakelets® Now Includes a Gluten-Free Line Certified By the GFCP. 3Health News:Dufflet Pastries® Impressive Collection of Brownies, Cakes, Pies and Cakelets® Now Includes a Gluten-Free Line Certified By the GFCP. 4
(Date:3/6/2015)... WILMINGTON, Del. , March 6, 2015 /PRNewswire/ ... Patent and Trademark Office,s publication of U.S. Patent ... Eating Disorder."  The ,249 Patent Application features claimed methods ... may be used to treat Binge Eating Disorder ... "information material," or "flyer or an advertisement," as ...
(Date:3/5/2015)... , March 5, 2015 BioLineRx (NASDAQ: ... biopharmaceutical company dedicated to identifying, in-licensing and developing ... commenced an underwritten public offering of American Depositary ... Ordinary Shares. All of the ADSs in the ... JMP Securities is acting as sole ...
(Date:3/5/2015)... 5, 2015  IRIDEX Corporation (Nasdaq: IRIX ) ... ended January 3, 2015.  , Revenues were $11.8 ... the Company and up 11% from $10.6 million in the ... a record, up 12% from $38.3 million in 2013. ... up from 48.6% in the fourth quarter of the prior ...
Breaking Medicine Technology:Lucerne Biosciences Announces Publication of Claimed Methods for Treating Binge Eating Disorder with Lisdexamfetamine Dimesylate 2BioLineRx Announces Underwritten Public Offering of its American Depositary Shares 2BioLineRx Announces Underwritten Public Offering of its American Depositary Shares 3IRIDEX Reports 2014 Fourth Quarter, Year-End Results 2IRIDEX Reports 2014 Fourth Quarter, Year-End Results 3IRIDEX Reports 2014 Fourth Quarter, Year-End Results 4IRIDEX Reports 2014 Fourth Quarter, Year-End Results 5IRIDEX Reports 2014 Fourth Quarter, Year-End Results 6IRIDEX Reports 2014 Fourth Quarter, Year-End Results 7IRIDEX Reports 2014 Fourth Quarter, Year-End Results 8
Cached News: